Immunogenicity and Therapeutic Efficacy of a Sendai-Virus-Vectored HSV-2 Vaccine in Mouse and Guinea Pig Models
CONCLUSIONS: The replication-defective recombinant Sendai viruses conveying HSV-2-gD and ICP27 proteins showed great immunogenicity and potential for preventing recurrent HSV-2 disease.PMID:38140157 | PMC:PMC10747028 | DOI:10.3390/vaccines11121752
Source: Herpes - Category: Infectious Diseases Authors: Xiuxiu Ren Wenhao Su Shishi Li Tingting Zhao Qiufang Huang Yinan Wang Xiaojie Wang Xiaohuan Zhang Jiangbo Wei Source Type: research
More News: Cold Sores | Genetics | Guinea Health | Herpes | Infectious Diseases | Outbreaks | Study | Vaccines